Related references
Note: Only part of the references are listed.A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)
Donita J. Africander et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor
Yashini Govender et al.
PLOS ONE (2014)
Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer
Mi Kyoung Kim et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
The Influence of Infertility Treatment on the Prognosis of Endometrial Cancer and Atypical Complex Endometrial Hyperplasia
Mari Ichinose et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer
Jeong-Yeol Park et al.
OBSTETRICS AND GYNECOLOGY (2013)
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis
Ioannis D. Gallos et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium
Hyun Park et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C)
Fuat Demirkiran et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Camille C. Gunderson et al.
GYNECOLOGIC ONCOLOGY (2012)
Cancer Incidence and Incidence Rates in Japan in 2005: Based on Data from 12 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project
Tomohiro Matsuda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis
Ioannis D. Gallos et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Fertility-Sparing Therapy in Young Women With Endometrial Cancer 2010 Update
Serkan Erkanli et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women
Seo Yeong Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2010)
Fertility-Sparing in Endometrial Cancer
Siriwan Tangjitgamol et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2009)
Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer
Ho-Suap Hahn et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Sparing fertility in young patients with endometrial cancer
Luis Chiva et al.
GYNECOLOGIC ONCOLOGY (2008)
Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer
Koji Yamazawa et al.
HUMAN REPRODUCTION (2007)
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
Kimio Ushijima et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium
Takeo Minaguchi et al.
CANCER LETTERS (2007)
Long-term conservative therapy for endometrial adenocarcinoma in young women
T Yahata et al.
HUMAN REPRODUCTION (2006)
One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above
S Klipstein et al.
FERTILITY AND STERILITY (2005)
Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger
T Ota et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature
KK Dhar et al.
GYNECOLOGIC ONCOLOGY (2005)
Outcome of fertility-preserving treatment in young women with endometrial carcinomas
K Niwa et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment
P Morice et al.
GYNECOLOGIC ONCOLOGY (2005)
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
PT Ramirez et al.
GYNECOLOGIC ONCOLOGY (2004)
Intrauterine progesterone treatment of early endometrial cancer
FJ Montz et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome
T Kaku et al.
CANCER LETTERS (2001)
Share Paper
